feed,title,long_url,short_url
InvestorPlace,DUOL Stock Soars on Q2 Earnings: What is Duolingo Doing Right?,https://investorplace.com/2024/08/duol-stock-soars-on-q2-earnings-what-is-duolingo-doing-right/,https://da.gd/Q3FjB
InvestorPlace,3 Streaming Service Stocks to Sell in August Before They Crash & Burn,https://investorplace.com/2024/08/3-streaming-service-stocks-to-sell-in-august-before-they-crash-burn/,https://da.gd/cfJMq
InvestorPlace,3 Game-Changing AI Stocks to Buy in August and Hold Forever,https://investorplace.com/2024/08/3-game-changing-ai-stocks-to-buy-in-august-and-hold-forever/,https://da.gd/ZAeo
InvestorPlace,Trade of the Day: Go Contrarian on Macy’s (M) Stock Death Cross,https://investorplace.com/2024/08/trade-of-the-day-go-contrarian-on-macys-m-stock-death-cross/,https://da.gd/fBxsjg
InvestorPlace,Why Lucid Investors Should Expect Further Declines From LCID Stock,https://investorplace.com/2024/08/why-lucid-investors-should-expect-further-declines-from-lcid-stock/,https://da.gd/Eot6SL
InvestorPlace,Ripple Triumphs: What the SEC’s ‘Not a Security’ Ruling Means for XRP,https://investorplace.com/2024/08/ripple-triumphs-what-the-secs-not-a-security-ruling-means-for-xrp/,https://da.gd/qzl2o
InvestorPlace,PBSFY Stock Earnings: ProSiebenSat 1 Media Reported Results for Q2 2024,https://investorplace.com/earning-results/2024/08/pbsfy-stock-earnings-prosiebensat-1-media-for-q2-of-2024/,https://da.gd/zr2v7C
InvestorPlace,KBCSY Stock Earnings: KBC Group Reported Results for Q2 2024,https://investorplace.com/earning-results/2024/08/kbcsy-stock-earnings-kbc-group-for-q2-of-2024/,https://da.gd/YXPQo9
InvestorPlace,MITEY Stock Earnings: Mitsubishi Estate Co Reported Results for Q1 2025,https://investorplace.com/earning-results/2024/08/mitey-stock-earnings-mitsubishi-estate-co-for-q1-of-2025/,https://da.gd/VC87I
InvestorPlace,"LPCN Stock Earnings: Lipocine Beats EPS, Misses Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/lpcn-stock-earnings-lipocine-for-q2-of-2024/,https://da.gd/tRhra
InvestorPlace,NATH Stock Earnings: Nathan’s Famous Reported Results for Q1 2025,https://investorplace.com/earning-results/2024/08/nath-stock-earnings-nathans-famous-for-q1-of-2025/,https://da.gd/zzuf
InvestorPlace,NUVL Stock Earnings: Nuvalent Misses EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/nuvl-stock-earnings-nuvalent-for-q2-of-2024/,https://da.gd/H44P7m
InvestorPlace,BNRE Stock Earnings: Brookfield Reinsurance Reported Results for Q2 2024,https://investorplace.com/earning-results/2024/08/bnre-stock-earnings-brookfield-reinsurance-for-q2-of-2024/,https://da.gd/WlOEKV
InvestorPlace,QTTB Stock Earnings: Q32 Bio Misses EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/qttb-stock-earnings-q32-bio-for-q2-of-2024/,https://da.gd/OPXXX
InvestorPlace,"RNAC Stock Earnings: Cartesian Therapeutics Beats EPS, Beats Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/rnac-stock-earnings-cartesian-therapeutics-for-q2-of-2024/,https://da.gd/6qk6CA
InvestorPlace,TRVN Stock Earnings: Trevena Beats EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/trvn-stock-earnings-trevena-for-q2-of-2024/,https://da.gd/vjlOxn
InvestorPlace,"VERV Stock Earnings: Verve Therapeutics Beats EPS, Beats Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/verv-stock-earnings-verve-therapeutics-for-q2-of-2024/,https://da.gd/qfrhs
InvestorPlace,"STER Stock Earnings: Sterling Check Misses EPS, Beats Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/ster-stock-earnings-sterling-check-for-q2-of-2024/,https://da.gd/MxneHp
InvestorPlace,ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/itos-stock-earnings-iteos-therapeutics-for-q2-of-2024/,https://da.gd/80uU
InvestorPlace,PASG Stock Earnings: Passage Bio Beats EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/pasg-stock-earnings-passage-bio-for-q2-of-2024/,https://da.gd/6xQYD
InvestorPlace,"FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Beats Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/fhtx-stock-earnings-foghorn-therapeutics-for-q2-of-2024/,https://da.gd/mwMs
InvestorPlace,SYBX Stock Earnings: Synlogic Beats EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/sybx-stock-earnings-synlogic-for-q2-of-2024/,https://da.gd/dXKW
InvestorPlace,"GLUE Stock Earnings: Monte Rosa Therapeutics Beats EPS, Beats Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/glue-stock-earnings-monte-rosa-therapeutics-for-q2-of-2024/,https://da.gd/QqcZC
InvestorPlace,CABA Stock Earnings: Cabaletta Bio Misses EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/caba-stock-earnings-cabaletta-bio-for-q2-of-2024/,https://da.gd/9tIz4i
InvestorPlace,CGEM Stock Earnings: Cullinan Therapeutics Misses EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/cgem-stock-earnings-cullinan-therapeutics-for-q2-of-2024/,https://da.gd/6C2RON
InvestorPlace,"HOWL Stock Earnings: Werewolf Therapeutics Misses EPS, Beats Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/howl-stock-earnings-werewolf-therapeutics-for-q2-of-2024/,https://da.gd/b1c5NE
InvestorPlace,"CARM Stock Earnings: CARISMA Therapeutics Beats EPS, Beats Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/carm-stock-earnings-carisma-therapeutics-for-q2-of-2024/,https://da.gd/8I9dq
InvestorPlace,XLO Stock Earnings: Xilio Therapeutics Misses EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/xlo-stock-earnings-xilio-therapeutics-for-q2-of-2024/,https://da.gd/a9jfF
InvestorPlace,TRML Stock Earnings: Tourmaline Bio Beats EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/trml-stock-earnings-tourmaline-bio-for-q2-of-2024/,https://da.gd/JaiYEg
InvestorPlace,"CQP Stock Earnings: Cheniere Energy Partners Beats EPS, Misses Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/cqp-stock-earnings-cheniere-energy-partners-for-q2-of-2024/,https://da.gd/hJbk
InvestorPlace,IMKTA Stock Earnings: Ingles Markets Reported Results for Q3 2024,https://investorplace.com/earning-results/2024/08/imkta-stock-earnings-ingles-markets-for-q3-of-2024/,https://da.gd/2VaHA
InvestorPlace,GANX Stock Earnings: Gain Therapeutics Misses EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/ganx-stock-earnings-gain-therapeutics-for-q2-of-2024/,https://da.gd/xUSF
InvestorPlace,ENG Stock Earnings: ENGlobal Reported Results for Q2 2024,https://investorplace.com/earning-results/2024/08/eng-stock-earnings-englobal-for-q2-of-2024/,https://da.gd/VVnLn
InvestorPlace,IPSC Stock Earnings: Century Therapeutics Beats EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/ipsc-stock-earnings-century-therapeutics-for-q2-of-2024/,https://da.gd/iw7rx2
InvestorPlace,CGON Stock Earnings: CG Oncology Beats EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/cgon-stock-earnings-cg-oncology-for-q2-of-2024/,https://da.gd/ADMsd
InvestorPlace,THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/thrd-stock-earnings-third-harmonic-bio-for-q2-of-2024/,https://da.gd/ZjHZ3
InvestorPlace,TOELY Stock Earnings: Tokyo Electron Reported Results for Q1 2025,https://investorplace.com/earning-results/2024/08/toely-stock-earnings-tokyo-electron-for-q1-of-2025/,https://da.gd/AgSZwv
InvestorPlace,VERA Stock Earnings: Vera Therapeutics Misses EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/vera-stock-earnings-vera-therapeutics-for-q2-of-2024/,https://da.gd/qmKHu
InvestorPlace,REPL Stock Earnings: Replimune Group Beats EPS for Q1 2025,https://investorplace.com/earning-results/2024/08/repl-stock-earnings-replimune-group-for-q1-of-2025/,https://da.gd/Pw3J
InvestorPlace,APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/apvo-stock-earnings-aptevo-therapeutics-for-q2-of-2024/,https://da.gd/8Qbba
InvestorPlace,DTEGY Stock Earnings: Deutsche Telekom Reported Results for Q2 2024,https://investorplace.com/earning-results/2024/08/dtegy-stock-earnings-deutsche-telekom-for-q2-of-2024/,https://da.gd/65giO
InvestorPlace,"VRDN Stock Earnings: Viridian Therapeutics Misses EPS, Misses Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/vrdn-stock-earnings-viridian-therapeutics-for-q2-of-2024/,https://da.gd/WleK9C
InvestorPlace,"FEMY Stock Earnings: Femasys Misses EPS, Misses Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/femy-stock-earnings-femasys-for-q2-of-2024/,https://da.gd/WLtB36
InvestorPlace,"TNC Stock Earnings: Tennant Beats EPS, Beats Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/tnc-stock-earnings-tennant-for-q2-of-2024/,https://da.gd/ztdaR
InvestorPlace,"EDR Stock Earnings: Endeavor Gr Hldgs Misses EPS, Misses Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/edr-stock-earnings-endeavor-gr-hldgs-for-q2-of-2024/,https://da.gd/v487
InvestorPlace,"SGA Stock Earnings: Saga Communications Beats EPS, Misses Revenue for Q2 2024",https://investorplace.com/earning-results/2024/08/sga-stock-earnings-saga-communications-for-q2-of-2024/,https://da.gd/qEfc8E
InvestorPlace,VIRI Stock Earnings: Virios Therapeutics Beats EPS for Q2 2024,https://investorplace.com/earning-results/2024/08/viri-stock-earnings-virios-therapeutics-for-q2-of-2024/,https://da.gd/yKVqN
InvestorPlace,"SIEGY Stock Earnings: Siemens Beats EPS, Misses Revenue for Q3 2024",https://investorplace.com/earning-results/2024/08/siegy-stock-earnings-siemens-for-q3-of-2024/,https://da.gd/JFj2P
InvestorPlace,Worried About a Recession? Don’t Be. Here’s What the Experts Are Saying.,https://investorplace.com/2024/08/worried-about-a-recession-dont-be-heres-what-the-experts-are-saying-recession-fears/,https://da.gd/mVMIM
InvestorPlace,The 3 Best Natural Gas Stocks to Buy Now: August Edition,https://investorplace.com/2024/08/the-3-best-natural-gas-stocks-to-buy-now-august-edition/,https://da.gd/zUmvt
